Mandate

Advokatfirman Vinge has advised the sellers in connection with Tencent Holdings Ltd acquisition of Sharkmob AB

May 23, 2019 M&A

Advokatfirman Vinge has advised the sellers of the Swedish game developer Sharkmob in connection with Tencent Holdings acquisition of the company for an undisclosed sum.

​Sharkmob was founded two years ago by a tight-knit group of industry veterans, and they have since grown steadily at their iconic Malmö office. The studio will continue working with its unannounced online game as well as several new projects together with Tencent Holdings.

Tencent Holdings is a Hong Kong based tech company whose internet solutions are used by over one billion netizens (citizen of the net). Their two principal business operations are social platforms and digital content and they are widely recognized as the biggest gaming company in the world.

The full press release can be found here www.sharkmob.com/press-release.

“We engaged Advokatfirman Vinge and Christian Riddarbo in this transaction due to the firm´s extensive expertise in complex cross-border transactions and in particular working with and for Chinese companies which we understand often require experience of Chinese business structures, decision-making processes and specific legal considerations.”, said Kristofer Westergren, former shareholder and resigning Chairman of Sharkmob.

Vinge’s team primarily consisted of Christian Riddarbo (M&A), Fredrik Sonander (M&A), Victor Ericsson (Tax), Jenny Sandlund (M&A), Hampus Wahlberg (General Corporate), Adam Loewenstein (General Corporate) and Camilla Andersson (VDR).

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025